HemaTechnologies has been a prominent player in the automated sed-rate testing industry for over 20 years. Established by a group of biomedical engineers and researchers, the company was founded with a vision to revolutionize the diagnostic and testing capabilities in the field of hematology.

Initially focusing on research and development, HemaTechnologies dedicated its early years to pioneering innovative solutions for blood analysis and sed-rate testing. This emphasis on technological advancement led to the creation of the cutting-edge ESR STAT PLUS, the small sample size sed rate analyzer capable of producing 3 results in 5 minutes.

Over the years, HemaTechnologies expanded its reach and influence within the medical community, forming strategic partnerships with leading healthcare institutions in the USA and internationally. Through continued investment in research and development, HemaTechnologies has upgraded the ESR STAT PLUS with the development of the ESR STAT 6. This expansion facilitated the widespread integration of the ESR STAT system into hospital laboratories and clinics, providing accurate, cost effective sed rate testing.

The company's unwavering commitment to innovation and quality has solidified its position as a trusted leader in the field of sed-rate testing. With a legacy built on scientific expertise and a dedication to providing excellent customer service, HemaTechnologies remains at the forefront of hematology technology, driving progress and innovation in the pursuit of enhanced healthcare.